Research

Found 6 results

Sort by: Author Title [ Year (Desc)]
Filters: Author is E. Hollander  [Clear All Filters]
2009
King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L et al..  2009.  Lack of Efficacy of Citalopram in Children with Autism Spectrum Disorders and High Levels of Repetitive Behavior. Archives of General Psychiatry. 66(6):583-590.
2008
Parikh MS, Kolevzon A, Hollander E.  2008.  Psychopharmacology of Aggression in Children and Adolescents with Autism: A Critical Review of Efficacy and Tolerability. Journal of Child and Adolescent Psychopharmacology. 18(2):157-178.
2006
Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.  2006.  Levetiracetam Versus Placebo in Childhood and Adolescent Autism: A Double-Blind Placebo-Controlled Study. International Clinical Psychopharmacology. 21(6):363-367.
Hollander E, Wasserman S, Swanson EN, Chaplin W, Schapiro ML, Zagursky K, Novotny S.  2006.  A Double-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder. Journal of Child and Adolescent Pharmacology. 16(5):541-548.
Bartz JA, Hollander E.  2006.  The Neuroscience of Affiliation: Forging Links between Basic and Clinical Research on Neuropeptides and Social Behavior. Hormones and Behavior. 50(4):518-528.
2003
Johnson SM, Hollander E.  2003.  Evidence that Eicosapentaenoic Acid is Effective in Treating Autism. J Clin Psychiatry.. 64(7):848-849.
Share |